Visceral adiposity in pediatric Crohn disease: phenotype or disease-activity biomarker?
Inflammatory Bowel Diseases · 02.11.2026
DOI: 10.1093/ibd/izag225 ↗Kurz gefasst
Editorial in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 02.11.2026. Verfasst von Ercan Yılmaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Allergy and Immunology, Faculty of Medicine, Inonu University, Malatya, Türkiye. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pediatric Allergy and Immunology, Faculty of Medicine, Inonu University, Malatya, Türkiye.
ORCID-Profile: Ercan Yılmaz, Nezihe Köker Özer, Erdem Topal
Zitieren
APA
Yılmaz, E., Köker Özer, N., & Topal, E. (2026). Visceral adiposity in pediatric Crohn disease: phenotype or disease-activity biomarker?. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag225
Vancouver
Yılmaz E, Köker Özer N, Topal E. Visceral adiposity in pediatric Crohn disease: phenotype or disease-activity biomarker?. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izag225
BibTeX
@article{Ylmaz2026,
author = {Yılmaz, Ercan and Köker Özer, Nezihe and Topal, Erdem},
title = {Visceral adiposity in pediatric Crohn disease: phenotype or disease-activity biomarker?},
journal = {Inflammatory Bowel Diseases},
year = {2026},
doi = {10.1093/ibd/izag225}
}
EUVIMED